SCHEMBL21940798

SCHEMBL21940798

CC1(C)OB(c2cn(CC3COCCO3)nc2C(F)(F)F)OC1(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21940456 0.80 CHRM2 (0.33) —
SCHEMBL20606970 0.77 — —
SCHEMBL20371661 0.76 FFAR1 (0.37) —
SCHEMBL21819814 0.75 FFAR1 (0.35) —
SCHEMBL15334053 0.75 FFAR1 (0.49) —
SCHEMBL15359061 0.75 FFAR1 (0.49) —
SCHEMBL15377247 0.75 FFAR1 (0.49) —
SCHEMBL30154016 0.74 FFAR1 (0.35) —
SCHEMBL21940571 0.73 LRRK2 (0.39) —
SCHEMBL21940795 0.73 LRRK2 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3423445-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS GALAPAGOS NV (BE) 2020-04-01 — — EP disclosed
Send feedback